Pricing Log in Create free account
Friday 6 November 2026 Export EW’s income statement to Excel — free account

Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.

Revenue
+10.5%
EPS
+6.00%
Free cash flow
−1.84%
Total debt
+0.10%

Quarter to September 2026, against a year earlier

101.39 0.57 +0.57%
Market cap
$58.1B
P/E
56.7×
Fwd P/E
36.5×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Edwards Lifesciences Corporation (EW) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Edwards Lifesciences Corporation (EW) trades at a EV/EBITDA of 34.0×. Over the past ten years it has ranged from 19.6× (December 2016) to 62.8× (June 2021); the current reading is higher than 67% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 33.0× 21.91%
FY2024 27.0× (13.45%)
FY2023 31.2× 11.34%
FY2022 28.1× (36.38%)
FY2021 44.1× (21.71%)
FY2020 56.3× 44.25%
FY2019 39.0× (0.15%)
FY2018 39.1× 97.17%
FY2017 19.8× (14.78%)
FY2016 23.3× 0.57%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 29.0× (4.74%)
Jun 2026 30.4× 4.41%
Mar 2026 29.1× (11.65%)
Dec 2025 33.0× 21.75%
43 more quarters

Against its own ten years

Low 19.6× High 62.8×
Ten-year median 29.6×
Current reading's percentile 67

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 11.1×
ZBH Zimmer Biomet Holdings, Inc. compare 12.1×
GEHC GE HealthCare Technologies Inc. compare 13.2×
BSX Boston Scientific Corporation compare 14.0×
STE STERIS plc compare 15.7×
MDT Medtronic PLC compare 15.7×
SYK Stryker Corporation compare 21.0×
DXCM DexCom, Inc. compare 21.2×
EW Edwards Lifesciences Corporation 34.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on EW